December 09, 2016 10:49 PM ET

Biotechnology

Company Overview of Alexion Pharmaceuticals, Inc.

Key Executives for Alexion Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
David L. Hallal 10 RelationshipsChief Executive Officer and Director50
Leonard Bell M.D.10 RelationshipsCo-Founder and Chairman 58
Vikas Sinha M.B.A., C.A., CPA11 RelationshipsChief Financial Officer and Executive Vice President53
Daniel A. Bazarko CPANo RelationshipsChief Accounting Officer and Senior Vice President--
Clare Carmichael No RelationshipsChief Human Resources Officer and Executive Vice President56
View More Key Executives

Alexion Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Leonard Bell M.D. 10 RelationshipsAlexion Pharmaceuticals, Inc.58
David L. Hallal 10 RelationshipsAlexion Pharmaceuticals, Inc.50
Andreas Rummelt Ph.D. 34 RelationshipsInterPharmaLink AG60
Ann M. Veneman J.D. 52 RelationshipsAlexion Pharmaceuticals, Inc.67
John T. Mollen 10 RelationshipsAlexion Pharmaceuticals, Inc.65
View All Board Members

Alexion Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Christopher J. Coughlin58 Relationships3 Executives
Compensation Committee John T. Mollen10 Relationships3 Executives
Nominating Committee J.D.Ann M. Veneman52 Relationships4 Executives
Corporate Governance Committee J.D.Ann M. Veneman52 Relationships4 Executives
Finance Committee Christopher J. Coughlin58 Relationships3 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$1.0M
1.0M
373.7K
Bonus
Not meaningful
Total Short Term Compensation$46.6M
Not meaningful
Total Value of Options$1.0M
1.0M
33.7M
Compensation as of Fiscal Year 2015
Alexion Pharmaceuticals, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Enterome SA Announces Executive Appointments
December 09, 2016 8:00 AM ET
Kite Pharma Appoints Jian Irish as Senior Vice President of Supply Chain
December 08, 2016 6:45 PM ET
Agenovir Appoints Dirk Thye as Chief Executive Officer and Member of the Board of Directors
December 08, 2016 12:30 PM ET
Ardelyx, Inc. Announces Management Changes
December 07, 2016 9:04 PM ET
IQuity Appoints Don M. Hardison to Board of Directors
December 07, 2016 7:44 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Alexion Pharmaceuticals, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.